Blog
RSS FeedPosted by Michael Wonder on 16 Nov 2020
Trump officials preparing to move forward with major step to lower Medicare drug prices
16 November 2020 - The Trump administration is preparing to move forward with a major proposal to lower drug prices, ...
Posted by Michael Wonder on 11 Nov 2020
CMS takes steps to ensure Medicare beneficiaries have wide access to COVID-19 antibody treatment
10 November 2020 - Coverage available at no cost to beneficiaries across variety of settings in health care system. ...
Posted by Michael Wonder on 08 Nov 2020
2021 Medicare Part B Premiums Remain Steady
6 November 2020 - Today, the Centers for Medicare & Medicaid Services announced the 2021 monthly Medicare Parts A and B ...
Posted by Michael Wonder on 05 Nov 2020
IQWiG publishes a new version of its general methods
5 November 2020 - New features include the investigation of volume-outcome relationships and different mean observation times in clinical studies. ...
Posted by Michael Wonder on 31 Oct 2020
2021 Federal Health Insurance Exchange open enrolment period starts on 1 November on HealthCare.gov
30 October 2020 - CMS is announcing that the open enrolment period for the Federal Health Insurance Exchange will officially ...
Posted by Michael Wonder on 28 Oct 2020
Medicare and Medicaid to cover early COVID-19 vaccine
26 October 2020 - The new regulations would allow beneficiaries to receive a vaccine under “emergency authorisation” at no cost. ...
Posted by Michael Wonder on 13 Oct 2020
Top Democrats call for watchdog to review Trump Medicare drug cards
13 October 2020 - Top-ranking Democrats want an independent watchdog to expedite a review of the Trump administration's plans to ...
Posted by Michael Wonder on 12 Oct 2020
Inventiva receives FDA breakthrough therapy designation for lead drug candidate lanifibranor in NASH
12 October 2020 - Inventiva today announced that the U.S. FDA has granted breakthrough therapy designation to lanifibranor, the Company’s lead ...
Posted by Michael Wonder on 05 Oct 2020
Real world evidence from a narrow therapeutic index product (levothyroxine) reflects the therapeutic equivalence of generic drug product
5 October 2020 - The National Institute of Diabetes and Digestive and Kidney Diseases reports that almost 5% of the U.S. ...
Posted by Michael Wonder on 25 Sep 2020
Innova Therapeutics receives rare paediatric disease designation from the FDA for IVT-8086 for the treatment of osteosarcoma
24 September 2020 - Innova Therapeutics Inc., a biopharmaceutical company committed to developing innovative cancer therapies for patients who have inadequate ...
Posted by Michael Wonder on 23 Sep 2020
Medicare wouldn’t cover costs of administering coronavirus vaccine approved under Emergency Use Authorisation
21 September 2020 - Trump administration officials are exploring options to quickly fix plan to make the vaccine free for all ...
Posted by Michael Wonder on 22 Sep 2020
New early scientific advice service to support medicine registrations
22 September 2020 - The Therapeutic Goods Administration has launched a new initiative - the Early Scientific Advice service - ...
Posted by Michael Wonder on 03 Sep 2020
CMS grants additional reimbursement for the Eluvia drug eluting vascular stent system
3 September 2020 - Boston Scientific announced that the U.S. Centers for Medicare and Medicaid Services granted a new technology add-on ...
Posted by Michael Wonder on 20 Aug 2020
EMA agrees to review UCB's bimekizumab
18 August 2020 - Information about marketing authorisation application to EMA not yet disclosed by UCB. ...
Posted by Michael Wonder on 03 Aug 2020
Medicare Part D plans rarely cover brand name drugs when generics are available
3 August 2020 - Study examines Medicare Part D coverage to quantify how often brand-name drugs are designated preferred over generics. ...